Natixis Advisors LLC Takes Position in CorVel Co. (NASDAQ:CRVL)

Natixis Advisors LLC bought a new position in shares of CorVel Co. (NASDAQ:CRVL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 14,437 shares of the business services provider's stock, valued at approximately $1,606,000.

Other large investors have also bought and sold shares of the company. FMR LLC raised its stake in shares of CorVel by 193.1% in the 3rd quarter. FMR LLC now owns 4,306 shares of the business services provider's stock valued at $1,408,000 after purchasing an additional 2,837 shares during the period. State Street Corp raised its position in CorVel by 0.8% in the 3rd quarter. State Street Corp now owns 360,068 shares of the business services provider's stock valued at $117,703,000 after buying an additional 2,959 shares during the last quarter. SkyView Investment Advisors LLC raised its position in CorVel by 1.6% in the 3rd quarter. SkyView Investment Advisors LLC now owns 4,351 shares of the business services provider's stock valued at $1,422,000 after buying an additional 67 shares during the last quarter. Victory Capital Management Inc. lifted its stake in CorVel by 152.8% in the 4th quarter. Victory Capital Management Inc. now owns 109,084 shares of the business services provider's stock valued at $12,137,000 after acquiring an additional 65,940 shares in the last quarter. Finally, Verition Fund Management LLC acquired a new position in CorVel during the 3rd quarter worth approximately $213,000. 51.36% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of CorVel from a "buy" rating to a "hold" rating in a report on Thursday, March 13th.

Remove Ads

CorVel Stock Performance

CRVL traded down $0.59 on Friday, hitting $111.36. 81,386 shares of the company were exchanged, compared to its average volume of 111,731. CorVel Co. has a 12 month low of $76.20 and a 12 month high of $128.61. The stock's fifty day moving average is $112.20 and its 200-day moving average is $114.34. The company has a market cap of $5.72 billion, a PE ratio of 65.51 and a beta of 1.06.

CorVel (NASDAQ:CRVL - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Insiders Place Their Bets

In other news, Director Steven J. Hamerslag sold 10,000 shares of the stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $123.48, for a total value of $1,234,800.00. Following the transaction, the director now directly owns 314,000 shares of the company's stock, valued at $38,772,720. This represents a 3.09 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Alan Hoops sold 10,200 shares of CorVel stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the sale, the director now directly owns 118,213 shares of the company's stock, valued at $13,758,811.07. The trade was a 7.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,200 shares of company stock valued at $3,824,115 over the last 90 days. 47.57% of the stock is currently owned by insiders.

CorVel Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.